Related references
Note: Only part of the references are listed.Adalimumab in the treatment of parotid sarcoidosis
Marta Cufi-Benet et al.
ARCHIVOS DE BRONCONEUMOLOGIA (2010)
Thalidomide Dramatically Improves the Symptoms of Early-Onset Sarcoidosis/Blau Syndrome Its Possible Action and Mechanism
Kozo Yasui et al.
ARTHRITIS AND RHEUMATISM (2010)
Apremilast, a cAMP phosphodiesterase-4 inhibitor, demonstrates anti-inflammatory activity in vitro and in a model of psoriasis
P. H. Schafer et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Cutaneous Sarcoidosis Occurring during Anti-TNF-Alpha Treatment: Report of Two Cases
F. Dhaille et al.
DERMATOLOGY (2010)
Novel TNF antagonists for the treatment of rheumatoid arthritis
Laisvyde Statkute et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2010)
Targeting the TNF-alpha pathway in sarcoidosis
Sabina A. Antoniu
EXPERT OPINION ON THERAPEUTIC TARGETS (2010)
Relapse of severe sarcoidosis with an uncommon peritoneal location after TNF alpha blockade. Efficacy of rituximab, report of a single case
Virginie Dasilva et al.
JOINT BONE SPINE (2010)
Abrupt Development of Sarcoidosis with a Prodromal Increase in Plasma Osteopontin in a Patient with Rheumatoid Arthritis During Treatment with Etanercept
Shino Takatori et al.
JOURNAL OF RHEUMATOLOGY (2010)
Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis
Christopher E. M. Griffiths et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Sarcoidosis Appearing During Anti-Tumor Necrosis Factor α Therapy: A New Class Effect Paradoxical Phenomenon. Two Case Reports and Literature Review
Alfonso Massara et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2010)
Ustekinumab: Lessons Learned from Targeting Interleukin-12/23p40 in Immune-Mediated Diseases
Michael Elliott et al.
CYTOKINE THERAPIES: NOVEL APPROACHES FOR CLINICAL INDICATIONS (2009)
Sarcoid sacroiliitis: successful treatment with infliximab
S. Agrawal et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
The Treatment of Lupus Pernio Results of 116 Treatment Courses in 54 Patients
Eleni Stagaki et al.
CHEST (2009)
Changes in Chest Roentgenogram of Sarcoidosis Patients During a Clinical Trial of Infliximab Therapy Comparison of Different Methods of Evaluation
Robert P. Baughman et al.
CHEST (2009)
Treating CNS sarcoidosis with infliximab and mycophenolate mofetil
James Corbett
Current Neurology and Neuroscience Reports (2009)
Novel targeted therapies for autoimmunity
E. William St Clair
CURRENT OPINION IN IMMUNOLOGY (2009)
Refractory Chronic Cutaneous Sarcoidosis Responsive to Dose Escalation of TNF-Alpha Antagonists
A-M. Thielen et al.
DERMATOLOGY (2009)
Treatment of Sarcoidosis
Christopher S. King et al.
DM DISEASE-A-MONTH (2009)
Golimumab for severe asthma
Sabina A. Antoniu
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Facial granulomatous nodules during etanercept treatment for psoriasis
Samimi Mahtab et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2009)
Uveitis associated with sarcoidosis exacerbated by etanercept therapy
Jun Suzuki et al.
JAPANESE JOURNAL OF OPHTHALMOLOGY (2009)
Infliximab induced skin and pulmonary sarcoidosis in a rheumatoid arthritis patient
Severine Josse et al.
JOINT BONE SPINE (2009)
Steroid-unresponsive neurosarcoidosis successfully treated with adalimumab
Michael Marnane et al.
JOURNAL OF NEUROLOGY (2009)
Disseminated Cryptococcal Infection and Anti-Tumor Necrosis Factor-α Treatment for Refractory Sarcoidosis: An Expected Association?
Laurent Arnaud et al.
JOURNAL OF RHEUMATOLOGY (2009)
Treatment of CNS sarcoidosis with infliximab and mycophenolate mofetil
Michael Moravan et al.
NEUROLOGY (2009)
Anti-TNF alpha therapy in systemic autoimmune and/or inflammatory diseases
Alexis Regent et al.
PRESSE MEDICALE (2009)
Infliximab therapy rescues cyclophosphamide failure in severe central nervous system sarcoidosis
Manica Sodhi et al.
RESPIRATORY MEDICINE (2009)
Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases
Claire Immediato Daien et al.
RHEUMATOLOGY (2009)
Adalimumab-induced noncaseating granuloma in the bone marrow of a patient being treated for rheumatoid arthritis
S. K. Metyas et al.
RHEUMATOLOGY INTERNATIONAL (2009)
Update on the treatment of peripheral arthritis in psoriatic arthritis
Enrique R. Soriano et al.
Current Rheumatology Reports (2009)
Markers of inflammation in sarcoidosis: Blood, urine, BAL, sputum, and exhaled gas
E. Bargagli et al.
CLINICS IN CHEST MEDICINE (2008)
Treatment of sarcoidosis
Robert P. Baughman et al.
CLINICS IN CHEST MEDICINE (2008)
Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial
M. A. Judson et al.
EUROPEAN RESPIRATORY JOURNAL (2008)
Rituximab as a treatment alternative in sarcoidosis
Ahlam Belkhou et al.
JOINT BONE SPINE (2008)
Targeting the Interleukin-12/23 Cytokine Family in the Treatment of Psoriatic Disease
Neil H. Shear et al.
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2008)
A Systematic Review of the Off-Label Use of Biological Therapies in Systemic Autoimmune Diseases
Manuel Ramos-Casals et al.
MEDICINE (2008)
Inoperable brain metastases from non-small cell lung cancer: what part does whole brain radiotherapy play in standard treatment?
Rachael Barton
THORAX (2008)
Sarcoidosis, role of tumor necrosis factor inhibitors and other biologic agents, past, present, and future concepts
Nadera J. Sweiss et al.
CLINICS IN DERMATOLOGY (2007)
Effectiveness of infliximab in treating selected patients with sarcoidosis
Samer Saleh et al.
RESPIRATORY MEDICINE (2006)
Thalidomide reduces IL-18, IL-8 and TNF-α release from alveolar macrophages in interstitial lung disease
Q. Ye et al.
EUROPEAN RESPIRATORY JOURNAL (2006)
Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement
Robert P. Baughman et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Adalimumab for treatment of cutaneous sarcoidosis
MP Heffernan et al.
ARCHIVES OF DERMATOLOGY (2006)
Ulcerative cutaneous sarcoidosis responding to adalimumab
MA Philips et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2005)
Tumor necrosis factor inhibition as a novel treatment for refractory sarcoidosis
NJ Sweiss et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2005)
Randomized, double-blind, placebo-controlled trial of infliximab in patients with chronic pulmonary sarcoidosis
RP Baughman et al.
CHEST (2005)
Etanercept for refractory ocular sarcoidosis - Results of a double-blind randomized trial
RP Baughman et al.
CHEST (2005)
Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases
JE Gottenberg et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Chronic sarcoid arthritis treated with intraarticular etanercept
Kathryn Hobbs
ARTHRITIS AND RHEUMATISM (2005)
Successful treatment of steroid-refractory neurosarcoidosis with infliximab
M Sollberger et al.
JOURNAL OF NEUROLOGY (2004)
Inhibition of cytokine release from alveolar macrophages in pulmonary sarcoidosis by pentoxifylline - Comparison with dexamethasone
ZH Tong et al.
CHEST (2003)
Etanercept for the treatment of stage II and III progressive pulmonary sarcoidosis
JP Utz et al.
CHEST (2003)
Increased circulating interleukin-12 (IL-12) p40 in pulmonary sarcoidosis
K Shigehara et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2003)
Alveolar macrophages are the main source for tumour necrosis factor-α in patients with sarcoidosis
H Fehrenbach et al.
EUROPEAN RESPIRATORY JOURNAL (2003)
IL-12 and IL-18 are increased and stimulate IFN-gamma production in sarcoid lungs
K Shigehara et al.
JOURNAL OF IMMUNOLOGY (2001)
Significance of the interleukin-1 receptor antagonist/interleukin-1β ratio as a prognostic factor in patients with pulmonary sarcoidosis
T Mikuniya et al.
RESPIRATION (2000)
Share Paper
